drugset / Trial / NCT00071695

Duloxetine vs. Active Comparator in the Treatment of Patients With Depression

NCT00071695

Phase 4 Completed 320 enrolled Eli Lilly and Company
RandomizedParallel-groupDouble-blindTreatment

Summary

How duloxetine compares to a medication currently available for the treatment of patients diagnosed with depression

Timeline

Start
2003-07
Primary completion
Completion
2004-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule
Subject Venlafaxine Small molecule

Indications